AustraliaDaily Briefs

Daily Brief Australia: Neuren Pharmaceuticals, Ionic Rare Earths and more

In today’s briefing:

  • Neuren Pharmaceuticals (NEU AU): Ready to Fly Again After a Breather
  • IXR Update Note IonicTech Magnet Recycling 05092024


Neuren Pharmaceuticals (NEU AU): Ready to Fly Again After a Breather

By Tina Banerjee

  • Neuren Pharmaceuticals (NEU AU) shares corrected ~14% over the last one month, as Daybue reported disappointing performance in U.S. and partner reduced 2024 revenue guidance for Daybue.
  • Muted U.S. performance of Daybue in 1H24 seems to be short-lived and the drug is expected to accelerate in 2H24 and beyond.
  • In 2Q24, the rate of new patient starts was 12% higher than the previous quarter and the rate of discontinuations was 46% lower than in the previous quarter. 

IXR Update Note IonicTech Magnet Recycling 05092024

By ACF Equity Research

  • Ionic Rare Earths Ltd (ASX:IXR) is a magnet (REOs) recycling (Belfast, UK) and REE mining explorer (Uganda) plus a Brazilian REE Refining JV, excluded from our NPV, with Viridis Mining and Metals Limited (VMM).
  • ACF visited IonicTech’s magnet recycling demo plant in July 2024.
  • Since our last IXR Flash Note, we raise our valuation by 16% to A$ 0.109 vs A$ 0.094 previously and put Makuutu in a maintenance period.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars